<DOC>
	<DOC>NCT01080768</DOC>
	<brief_summary>The purpose of the present study was to evaluate the addition of aliskiren, to amlodipine can attenuate ankle edema formation in hypertensive patients.</brief_summary>
	<brief_title>Assessment of Aliskiren/Amlodipine and Amlodipine on Ankle Foot Volume (AFV) in Patients With Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Amlodipine</mesh_term>
	<criteria>Patients (male or female) with hypertension aged between 1875 yrs. Patients not treated with amlodipine or no amlodipine in previous 1 year. Postmenopausal females Patients unable to switch from prior hypertensive medication. Severe hypertension. Pregnant or nursing females. Patients with Type 1 or Type 2 diabetes mellitus History of immunodeficiency diseases, including a positive Human immunodeficiency virus (HIV) (Enzymelinked immunosorbent assay [ELISA] and Western blot) test result. A positive Hepatitis B surface antigen (HBsAg) or Hepatitis C test result. Other protocoldefined inclusion/exclusion criteria are applied</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Pedal edema</keyword>
	<keyword>hypertension</keyword>
	<keyword>aliskiren</keyword>
	<keyword>amlodipine</keyword>
</DOC>